Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. - Wikidata - awgldk - TriplyDB

Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.

Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.

http://www.wikidata.org/entity/Q33797179

about

Hostile takeovers: viral appropriation of the NF-kB pathway Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2 Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Barr virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review)The Rel/NF-kappaB signal transduction pathway: introduction Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40 TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1 Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity Mutant human cells with constitutive activation of NF-kappaB Primary central nervous system lymphoma expressing the human neurotropic polyomavirus, JC virus, genome.LMP1+SLAMF1high cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells.Epstein-Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity.EVM005: an ectromelia-encoded protein with dual roles in NF-κB inhibition and virulence Series introduction: the transcription factor NF-kappaB and human disease Molecular pathways in virus-induced cytokine production.The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1 Virus and cell RNAs expressed during Epstein-Barr virus replication EBV in Hodgkin Lymphoma.Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.CD20 antibody primes B lymphocytes for type I interferon production.Interferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation.Epstein-Barr virus down-regulates tumor suppressor DOK1 expression.Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associat NF-kappaB2 mutation targets TRAF1 to induce lymphomagenesis.Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes Reovirus receptors, cell entry, and proapoptotic signaling.Saikosaponin A inhibits influenza A virus replication and lung immunopathology.Promotion of Hendra virus replication by microRNA 146a Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes.EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration.Comparative analysis of oncogenic properties and nuclear factor-kappaB activity of latent membrane protein 1 natural variants from Hodgkin's lymphoma's Reed-Sternberg cells and normal B-lymphocytes Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1.NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma.NF-κB as a target for oncogenic viruses.Modulation of autophagy-like processes by tumor viruses.Lymphoblastoid Cell lines: a Continuous in Vitro Source of Cells to Study Carcinogen Sensitivity and DNA Repair At a crossroads: human DNA tumor viruses and the host DNA damage response.

P2860

Q22241900-8F3874F3-08C9-42BA-92E2-A3244DE046D3 Q24646670-0898D601-3630-4C55-BD8A-CDDF7E31FE68 Q24674848-51E8289F-3AB4-4B1E-8A7D-0949409BDE68 Q24675683-57D977E2-C24E-4A85-A690-4DDE669DACA1 Q26799398-62393F8D-E339-49DC-8927-866EF9190F4B Q28140718-7478A5B6-15F3-435B-BF87-F8B9AC218ACE Q28207648-1692B388-E8E7-4052-8BDA-B0BEC1D6257F Q28361340-5E74A4E6-5823-4081-BE0F-A8E917247BCF Q28383134-9793AF27-E8AB-437E-957F-C11D7DDB2EC2 Q31033964-A2D8BBC9-16D2-4555-82B6-8D53A93C22EC Q33199393-61D3324A-FE44-4AE8-B65D-743B938E4740 Q33648588-5890C962-C6DB-4D29-8352-4BA0E6A29C0C Q33884691-093A7942-F36D-4D05-BC2C-270170E7BD14 Q34047542-8DA4A91A-9A61-46E5-98E3-D5ED6462CB82 Q34116362-85F46BEE-B6F1-4C32-8092-642F83F9E5E1 Q34174972-0C633419-63AD-4EA7-B140-5AF76131FC67 Q34384112-C8F01273-37FE-435B-901E-B76C16E78ED8 Q34405076-5190F846-42F0-4870-9A7F-8C002054E9BC Q34434702-215AE0E0-19A2-47A5-8D69-300A2FFBA9EB Q34549468-3E2F3C69-18FA-4598-8C25-D5BA43EDD385 Q34789652-718E09A5-12F6-4FC7-AB5B-171E87E3DADF Q34846171-177B1875-8DEB-4BC8-8F22-FE91F689A9F4 Q34979127-A69FA0EC-A515-402B-9C22-952480FC2870 Q35165290-0F2FBA09-E095-4F8E-819C-128EC927268D Q35757197-8279C39E-10DC-42EF-A0F5-E7408D21761F Q35900991-5C2FF86D-C914-4551-ADB8-B31B695C5CBA Q36403897-911A9819-E4B4-45B6-8EAA-695AA4F5FA09 Q36494593-B465A5B6-D461-4E22-870C-65EE0B91488C Q36618923-435BC738-46A5-4502-AC41-C57B77B4A7C5 Q36759724-D7D762E0-CD2B-4BF1-A11B-DEEFA812994C Q36933913-8BD41F5E-00C7-4969-BA95-DE7BA5E18484 Q36994005-682C2864-CD6B-43C0-AF94-25936EF4D884 Q37112849-788F9BD5-4E8E-4F63-B09E-4526725889D0 Q37247067-F2F3A8F7-AEDF-4FEF-B237-E45F56C1ECBD Q37286365-A3696C55-ADBA-4440-AEEF-C4403EE68739 Q37355725-03E55A89-0142-45E5-9C77-A4CB9423175C Q37374081-B3D1EB1B-2168-483A-A3B3-FBB303DF7ACD Q37512255-5E1DAA4B-667C-41D0-A9FD-9A828EDE2869 Q38189401-ED736D4D-949E-4535-88AF-318E9A560CC1 Q38388893-24371F7C-19AC-4444-9721-092E4C9A1DFB

P2860

Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.

http://www.wikidata.org/entity/Q33797179

description

1999 nî lūn-bûn

@nan

1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Epstein-barr virus transformat ...... iated activation of NF-kappaB.

@ast

Epstein-barr virus transformat ...... iated activation of NF-kappaB.

@en

type

label

Epstein-barr virus transformat ...... iated activation of NF-kappaB.

@ast

Epstein-barr virus transformat ...... iated activation of NF-kappaB.

@en

prefLabel

Epstein-barr virus transformat ...... iated activation of NF-kappaB.

@ast

Epstein-barr virus transformat ...... iated activation of NF-kappaB.

@en

P1433

Q33797179-8054B6B7-2B25-4EE3-8A1F-B5407235CA55

P1476

Q33797179-50C7F40A-8029-4AFF-BB91-4F27B84014FF

P2093

Q33797179-2CA1CC86-7DDC-4A08-BE46-DC1563E86A8B

Q33797179-2EE4C5DF-2356-4CCE-9D81-9C1CBE858A94

Q33797179-60D5EF37-43B5-4666-8C62-E69A191C9007

P2860

Q33797179-0084AF54-6DBF-4D01-BC28-43CCD4CE48CF

Q33797179-065848D6-C0F4-4947-A327-C461D30C800D

Q33797179-0DCFFE4C-1456-4B49-BB75-DC139D0DF724

Q33797179-0DFCB6A7-D62D-4B9E-B787-907C5CFFAB08

Q33797179-131D282F-0DB8-41CF-9E64-78CBB2C6E7A5

Q33797179-142A22DE-84AF-4B0B-90A7-5F5550E66421

Q33797179-14D2AF5F-4480-4EE7-BCEA-3C4EF8B00D02

Q33797179-14D6A5A2-7360-441B-B398-3686B3945F07

Q33797179-1613C093-8B5C-4500-8643-11DEE74E7E18

Q33797179-268B7EDF-F729-4D28-A78E-CF8571EA8BC2

P2888

Q33797179-71695C29-AD87-43EA-9E66-2D59AF8B32C5

P304

Q33797179-50448A70-80B8-4DAE-8A8E-E415C2217C8C

P31

Q33797179-3F7C902C-502D-48A1-9689-686A7E0C1502

P356

Q33797179-ECB1000C-95F3-4843-94C4-6C4D82B6E643

P407

Q33797179-F74328F1-0E5C-4BB1-9019-C196625EB592

P433

Q33797179-5A9E504C-A479-4C00-B90F-FCD7F0A5D2E7

P478

Q33797179-0C6887D5-206C-4E4E-AF3C-A16951CC9BB1

P577

Q33797179-0AAF4581-52B9-46CE-A205-4F7239D39752

P5875

Q33797179-234ED0A5-12E1-40C3-AA60-3100D9A9D9F7

P6179

Q33797179-91E20128-F377-4424-A555-1E341BD1C98E

P698

Q33797179-2F392E0B-1EB6-4B8A-B116-7B26EB922ED8

P921

Q33797179-4348775A-00BD-4445-ABE0-BE1216ADAAF3

Q33797179-4DA6D2C9-CEC4-42A8-B6DF-3CEBFBFD2443

P356

P1433

P1476

Epstein-barr virus transformat ...... iated activation of NF-kappaB.

@en

P2093

E D Cahir McFarland

http://www.w3.org/2001/XMLSchema#string

G Mosialos

http://www.w3.org/2001/XMLSchema#string

K M Izumi

http://www.w3.org/2001/XMLSchema#string

P2860

The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation

Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis

The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB

Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40

The death domain kinase RIP mediates the TNF-induced NF-kappaB signal

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.

P2888

P304

6959-6964

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1203217

http://www.w3.org/2001/XMLSchema#string

P407

P433

49

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

1999-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12699889

http://www.w3.org/2001/XMLSchema#string

P6179

1006150546

http://www.w3.org/2001/XMLSchema#string

P698

10602470

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus